Clicky

Ocugen Inc(2H51) News

2H51 price today by TradingView
Date Title
Jun 5 Ocugen, Inc. Announces Signing of Binding Term Sheet for the License of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea
Feb 13 Why Ocugen (OCGN) Is Advancing Today
Feb 12 Ocugen, Inc. Announces Dosing Completion in the Phase 2 ArMaDa Clinical Trial for OCU410—a Multifunctional Modifier Gene Therapy for the Treatment of Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration